Arthrogryposis Multiplex Congenita Neurogenic Type
Symptoms, Doctors, Treatments, Advances & More

Arthrogryposis Multiplex Congenita Neurogenic Type Overview

Save information for later
Sign Up

Learn About Arthrogryposis Multiplex Congenita Neurogenic Type

What is the definition of Arthrogryposis Multiplex Congenita Neurogenic Type?
Arthrogryposis multiplex congenita neurogenic type (AMCN) refers to the development of multiple joint contractures affecting two or more areas of the body prior to birth. A contracture occurs when a joint becomes permanently fixed in a bent or straightened position, which can impact the function and range of motion of the joint and lead to muscle atrophy. Signs and symptoms of AMCN vary. AMCN can affect upper and lower joints, including the wrists, elbows, fingers, knees, ankles, and hip. In AMCN, arthrogryposis occurs as a result of the abnormal development of cells in the spinal cord (anterior horn cells) or brainstem (motor nuclei). AMCN often occurs sporadically (in a person with no family history of the condition), however families with multiple affected members have also been reported. In most cases, the underlying genetic cause remains unknown.
What are the alternative names for Arthrogryposis Multiplex Congenita Neurogenic Type?
  • Arthrogryposis multiplex congenita neurogenic type
  • AMC, neurogenic type
  • AMCN
  • Neurogenic type of AMC
Who are the top Arthrogryposis Multiplex Congenita Neurogenic Type Local Doctors?
Elite in Arthrogryposis Multiplex Congenita Neurogenic Type
Elite in Arthrogryposis Multiplex Congenita Neurogenic Type
Referral may be required

UCL Queen Square Institute Of Neurology

London, ENG, GB 

Alexander Rossor practices practicing medicine in London, United Kingdom. Mr. Rossor is rated as an Elite expert by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Arthrogryposis Multiplex Congenita Neurogenic Type, Spinal Muscular Atrophy with Arthrogryposis, and Primary Lateral Sclerosis.

Experienced in Arthrogryposis Multiplex Congenita Neurogenic Type
Internal Medicine
Experienced in Arthrogryposis Multiplex Congenita Neurogenic Type
Internal Medicine

ProMedica Physicians Health Specialists Of Lenawee

6869 S Occidental Rd, 
Tecumseh, MI 
Languages Spoken:
English
Accepting New Patients

Dennis Shelle is a primary care provider, practicing in Internal Medicine in Tecumseh, Michigan. Dr. Shelle is rated as an Experienced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Pneumoconiosis, Rheumatoid Lung Disease, Ankylosing Spondylitis, and Axial Spondyloarthritis (AxSpA). Dr. Shelle is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Arthrogryposis Multiplex Congenita Neurogenic Type
Experienced in Arthrogryposis Multiplex Congenita Neurogenic Type
Referral may be required
26W171 Roosevelt Rd, 
Wheaton, IL 
Languages Spoken:
English, Filipino
Accepting New Patients
Offers Telehealth

Norman Aliga is a Physiatrist practicing medicine in Wheaton, Illinois. Dr. Aliga is rated as an Experienced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Foot Drop, Paraplegia, Guillain-Barre Syndrome, and Miller-Fisher Syndrome. Dr. Aliga is board certified in American Board Of Physical Medicine And Rehabilitation - Physical Medicine & Rehabilitation (Certified). Dr. Aliga is currently accepting new patients.

What are the latest Arthrogryposis Multiplex Congenita Neurogenic Type Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center